Story perspectives

Global Health Crisis: Antimicrobial Resistance Costs Soar Without Action

10/28/2025

47 7

Summary

Story summary

Antimicrobial resistance (AMR) remains a global health issue, prompting a One Health approach across human, animal, and environmental health.
The Center for Global Development warns that without intervention, healthcare costs in high-income countries could rise by $176 billion annually due to AMR.
Innovative funding models are emerging, such as United Kingdom’s fixed payments for new antibiotics.
The U.S. government is investing in antibiotic research through CARB-X, supporting early-stage antibacterial development.

1 of 1

Story summary

Antimicrobial resistance (AMR) remains a global health issue, prompting a One Health approach across human, animal, and environmental health.
The Center for Global Development warns that without intervention, healthcare costs in high-income countries could rise by $176 billion annually due to AMR.
Innovative funding models are emerging, such as United Kingdom’s fixed payments for new antibiotics.
The U.S. government is investing in antibiotic research through CARB-X, supporting early-stage antibacterial development.